RecruitingNot ApplicableNCT04574336

Scandinavian Humeral Diaphyseal Fracture Trial

Scandinavian Humeral diAphyseal Fracture Trial - A Pragmatic Randomized Controlled Trial


Sponsor

Kolding Sygehus

Enrollment

287 participants

Start Date

Apr 4, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This pragmatic multicenter randomized controlled trial (RCT) includes adult participants with an acute humeral shaft fracture to compare surgical fixation of humeral shaft fracture to non-surgical treatment with early identification and treatment of delayed union by a patient-reported outcome after 52 weeks. The trial population of 287 participants The trial population is divided in two age-groups due to the changes in DASH score by age. The definition of delayed union differs in the young and elderly population to consider dissimilarity in bone healing rates and the timepoint for crossover is therefor different between the groups. Participants will be randomized 1:1 between non-surgical treatment and surgical treatment. The primary outcome is the Disability of Arm, Shoulder and Hand (DASH) score at 52 weeks, and is assessor blinded. The secondary outcomes are DASH score earlier than 52 weeks, EQ-5D-5L, pain assessed by visual analogue score, Constant-Murley score including elbow range of motion and anchor-questions collected at all timepoints throughout the trial. All complications will be reported including; infection, nerve or vascular injury, surgical revisions (implant malpositioning, hardware failure, aseptic loosening and peri-implant fracture), major adverse cardiovascular events, other major adverse events and mortality. SHAFT will provide information on the effectiveness of two standard treatments for humeral shaft fractures, while taking the dilemmas within the population into account.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Fracture types 12A-C (OTA/AO classification)
  • a. Includes minimal displaced extra-articular fracture extensions to the proximal humerus (less than a 1 cm or 45 degree angulation)
  • Treatment within 14 days from trauma
  • Age 18-64 years for SHAFT-Y and ≥65 years for SHAFT-E
  • Patients must understand the information given and be able to read and speak Danish, Swedish or Norwegian to complete the study paperwork
  • All fracture extensions involving the distal humerus and displaced fracture extensions involving the proximal humerus will not be included. Isolated fractures to the proximal or the distal end of the humerus are not eligible for screening. The proximal and distal end segments of the humerus are defined by squares of which the sides are the widest length of the epiphysis/metaphysis in question on the anterior-posterior view.

Exclusion Criteria8

  • Inability to give informed consent
  • Undisplaced shaft fracture (less than a cortex-wide displacement in all radiographic plane)
  • Vascular injury in ipsilateral arm
  • Polytrauma (defined as a trauma with one or more concurrent fractures to the upper extremities or other trauma absolute indications for surgical intervention)
  • Pathological fracture
  • Open fracture
  • BMI > 40
  • Health conditions preventing either treatment

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURESurgical treatment

We anticipate that surgical treatment will include plate osteosynthesis (MIPO and ORIF), intramedullary nailing (antegrade and retrograde) and external fixation. Plate and nail types, screw configuration and surgical approaches will be decided by the surgeon. The procedure will be conducted or supervised by a senior consultant.

DEVICENon-surgical treatment

Non-surgical treatment will include sugar tong, splint, plaster splints, hanging casts, or functional bracing as the Sarmiento brace and will be worn until a surgeon removes it. If the surgeon deems it appropriate, participants will be offered to undergo early secondary surgery with a surgical procedure of their choice. The participants will be recorded and the reason will be noted. We anticipate the surgical procedures will be similar to the previous mentioned and perhaps with the addition of bone graft.


Locations(22)

Aabenraa Hospital

Aabenraa, Denmark

Aarhus Hospital

Aarhus, Denmark

Bispebjerg Hospital

Copenhagen, Denmark

Hvidovre Hospital

Copenhagen, Denmark

Esbjerg Hospital

Esbjerg, Denmark

Aalborg-Farsø Hospital

Farsø, Denmark

Herlev-Gentofte Hospital

Gentofte Municipality, Denmark

New North Zealand Hospital

Hillerød, Denmark

Holbæk Hospital

Holbæk, Denmark

Kolding Hospital

Kolding, Denmark

Zealand University

Køge, Denmark

Odense Hospital

Odense, Denmark

Slagelse Hospital

Slagelse, Denmark

Viborg Regional Hospital

Viborg, Denmark

Helsinki University Hospital

Helsinki, Finland

Tampere University Hospital

Tampere, Finland

Oslo University Hospital (Ullevål)

Oslo, Norway

Stanvanger University Hospital

Stavanger, Norway

Danderyd University Hospital

Stockholm, Sweden

Karolinska University Hospital

Stockholm, Sweden

Umeå University Hospital

Umeå, Sweden

Uppsala University Hospital

Uppsala, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04574336